Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.

Autor: Chang JE; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Havighurst T; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Kim K; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Eickhoff J; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Traynor AM; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Kirby-Slimp R; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Volk LM; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Werndli J; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Go RS; Gunderson Health System, La Crosse, WI, USA., Weiss M; ThedaCare Cancer Care, Appleton, WI, USA., Blank J; Green Bay Oncology and the Saint Vincent Regional Cancer Center, Green Bay, WI, USA., Kahl BS; Washington University, St. Louis, MO, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (2), pp. 283-91. Date of Electronic Publication: 2016 Feb 23.

Recent advances in therapy of chronic lymphocytic leukaemia.

Autor: Routledge, David J. M., Bloor, Adrian J. C.

Publikováno v: British Journal of Haematology; Aug2016, Vol. 174 Issue 3, p351-367, 17p